Who invested in Umoja Biopharma?
Umoja Biopharma's investors include DCVC, Temasek Holdings, SoftBank, SoftBank Vision Fund and Cormorant Asset Management, and 2 more on record.

United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$100Mraised across 1 round since 2025, from 1 source
Source recorded
From Umoja Biopharma's own website and the SEC filings it signed: 5 on the team.
On the board, as filediAnna S. FrenchJohn S. HamerLuke S. EvninPhilip S. LowRobert S. Glassman
Umoja Biopharma's investors include DCVC, Temasek Holdings, SoftBank, SoftBank Vision Fund and Cormorant Asset Management, and 2 more on record.
Umoja Biopharma has raised $100M across 1 round since 2025.
Umoja Biopharma's most recent round was a Series C of $100M in Jan 2025.
Its most recent round, $100M in Jan 2025, is also its largest on record.
Umoja Biopharma's first round on record, in Jan 2025, was backed by DCVC, Temasek Holdings and SoftBank and 4 others.
Umoja Biopharma's latest named round is a Series C, in Jan 2025.
Umoja Biopharma is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.